Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma, T-Cell, Cutaneous × vandetanib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 10 Carcinoma, Medullary 9 Thyroid Neoplasms 7 Lung Neoplasms 6 Neoplasm Metastasis 5 Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Ovarian Neoplasms 3 Carcinoma, Renal Cell 3 Prostatic Neoplasms 2 Kidney Neoplasms 2 Gliosarcoma 2 Glioblastoma 2 Familial medullary thyroid carcinoma 2 Fallopian Tube Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Thyroid cancer, medullary 1 Thyroid Diseases 1 Thyroid Cancer, Papillary 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Precancerous Conditions 1 Pleural Effusion 1 Peritoneal Neoplasms 1 Oligodendroglioma 1 Multiple Endocrine Neoplasia Type 2b 1 Multiple Endocrine Neoplasia Type 2a 1

Interventions

fludarabine phosphate 20 Peripheral Blood Stem Cell Transplantation 16 Whole-Body Irradiation 15 Mycophenolic Acid 14 Cyclophosphamide 13 Antilymphocyte Serum 13 Busulfan 12 Tacrolimus 11 Cyclosporine 11 Melphalan 9 Methotrexate 8 Rituximab 7 Etoposide 7 Flow Cytometry 6 Filgrastim 6 romidepsin 5 Vorinostat 5 Dexamethasone 5 thymoglobulin 4 Sirolimus 4 Granulocyte Colony-Stimulating Factor 4 Calcium Dobesilate 4 Bexarotene 4 Alemtuzumab 4 fludarabine 3 Therapeutics 3 Lenalidomide 3 Everolimus 3 Cord Blood Stem Cell Transplantation 3 Carboplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡